CAR T-cell therapy is a cancer treatment in which a patient’s immune system T cells are genetically modified to mount a more effective attack on cancer. As of May 2018, CAR T-cell therapy has been approved by the U.S. Food and Drug Administration as standard therapy for some adult patients with aggressive non-Hodgkin lymphoma that has relapsed after … Read more
Like many of Dana-Farber’s youngest patients, 3-year-old Hannah Packman brought a favorite plaything to each of her Jimmy Fund Clinic visits. Lulu the doll, however, was unique because of the extra attention she received from pediatric social worker Deborah Berk, LICSW. When Hannah had a blood draw, Berk arranged for Lulu to have one as … Read more
Washington, D.C., can be a frenzied place, especially for a college student juggling a full class load and congressional internships on Capitol Hill. Jen Fox, however, is taking it all in stride. How does she stay so calm? Well, Fox suggests, two bouts with Hodgkin lymphoma in three years, and a stem cell transplant at … Read more
In the high-stakes contest of hide-and-seek between cancer cells and the human immune system, the advantage doesn’t always lie with the body’s defenders. A new approach to treatment, known as CAR T-cell therapy, may shift that balance of power. Cancer cells conceal themselves from the immune system not by barricading themselves in an impenetrable shell, … Read more
When Emily Coughlin complained of a sore knee in May 2009, doctors initially suspected Lyme disease. After antibiotics failed to relieve the pain, the girl, who was just shy of her fourth birthday, was diagnosed with neuroblastoma, a cancer that begins in nerve cells outside the brain and usually affects children under 6. Though rare … Read more
Jessica Madsen wasn’t sure if her daughter, Addy, was ready for karate, until the 4-year-old got the chance to take free lessons in the most surprising place: Her hospital room. Addy and other stem cell transplant recipients at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center are offered free martial arts coaching during their inpatient recovery … Read more
On September 24, 2015, in a sixth floor room at Boston Children’s Hospital, 5-year-old Logan Lesselroth pressed the button that started the transfer of his newly harvested blood stem cells to his 3-year-old sister, Gianna. “This,” Gianna told him, “is a gift from your body.” The path to that moment and the stem cell transplant’s … Read more
Mary Taber’s marathon training requires a singular focus. It is demanding, solitary, life-affirming – not unlike her treatment five years ago for aplastic anemia and paroxysmal nocturnal hemoglobinuria (PNH). Taber, intranet editor at Dana-Farber, will mark five years from her March 2011 bone marrow transplant by taking to the storied Boston Marathon® route on April … Read more
Drew D’Auteuil is a 17-year-old animal-loving, skiing, rowing, volleyball- playing, honor roll student with braces and a shock of red hair. Although he may seem like a typical teen, D’Auteuil has survived rare, life-threatening complications of a stem cell transplant for severe aplastic anemia. “It’s eye-opening to realize how fragile life really is when you’re … Read more
Stem cell transplantation can be a life-saving treatment option for patients with blood cancers or disorders. The procedure, sometimes called bone marrow transplantation, replaces bone marrow that doesn’t work correctly or has been damaged by disease. We spoke with Joseph Antin, MD, chief of the Stem Cell Transplantation Program at Dana-Farber/Brigham and Women’s Cancer Center, … Read more
Medically reviewed by Paul Richardson, MD By Maria Pearson As a technology teacher who had a long career with IBM before going into education, I have encountered all sorts of opportunities to teach — and to learn. The biggest such opportunity of my life occurred at the intersection of cancer, technology, and Dana-Farber. In August … Read more
Faces of Childhood Cancer: Sarah Levin Sarah Levin is 11 years old, and has beaten acute lymphoblastic leukemia (ALL) twice. This is her story. The first time I got diagnosed with ALL I was only three, so I don’t remember that much about it. But what my mom and dad have told me is that … Read more
When Lauren Leonard bounces across the stage, she is in perfect harmony with the rhythm of the music. Amongst a group of other dancers, she stands out, moving with tangible energy. Dancing has been an important part of Leonard’s life since childhood. She started taking ballet lessons when she was 5, and as a teenager … Read more
After Lacey Martin’s leukemia didn’t respond to initial rounds of chemotherapy and after she spent 10 weeks hospitalized for a stem cell transplant, the 11-year-old New Hampshire girl went home March 2 with an external line for medications that her mother would have to flush and clean twice a day. Lacey’s immune system and infection-fighting … Read more
Ana Karen Ventura may be a long way from home, but it sure doesn’t feel like it. Ventura, 11, is an inpatient at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, but her hospital room at Boston Children’s Hospital looks more like the bedroom of any tween girl. There are posters of flowers and her favorite … Read more
On International Childhood Cancer Day, it’s important to remember that global support, research, and treatment are vital to ensuring that children in developing countries have the same chance at survival as their peers in the U.S. Physicians such as Dr. Leslie Lehmann from Dana-Farber/Boston Children’s Cancer and Blood Disorders Center travel all over the world … Read more
When the time came for Jeffrey Ferreira to undergo a stem cell transplant for acute myeloid leukemia (AML), his Dana-Farber hematologist, Corey Cutler, MD, MPH, had some intriguing news: he was eligible for a clinical trial of a new approach to lowering the risk of chronic graft-versus-host disease (GVHD), a common and sometimes severe aftereffect … Read more
Results of several phase 3 trials and dozens of other studies led by Dana-Farber researchers were presented online and in person June 3-7 at the 2022 Annual Meeting of the American Society of Clinical Oncology (ASCO), the world’s largest clinical cancer research meeting. Some of the research reports presented by Dana-Farber investigators include: Improved progression-free … Read more
Acute myeloid leukemia (AML) is the second most common leukemia diagnosed in children. It is hard to treat and can be fatal in some cases. While there have been some recent successes with genetically targeted therapies for adults, AML has different genetic features in children, and care has been slow to advance. “The state of care … Read more
If transgender youth and adults are undergoing (or planning) gender-affirming surgery, taking masculinizing or feminizing hormones, and they have cancer, these treatments can have implications for their care. Cancer treatments in turn can have implications for their gender-affirming care. Oncologists should take gender identity into account in making decisions about cancer treatment. This starts with … Read more